Topical Gel Promising in Migraine Trial

A fast-acting transdermal gel using a proprietary formulation of the non steroidal anti-inflammatory drug (NSAID) ketoprofen reduced pain severity in patients with severe migraine with and without aura, compared with placebo and had few adverse effects. “This...
Subscribe To Our Weekly Newsletter

Subscribe To Our Weekly Newsletter

Get a weekly digest of our posts straight to your inbox! We promise, no spam ever.

You have Successfully Subscribed!

Pin It on Pinterest